Literature DB >> 16835697

Association of CYP2D6 100 C > T and 2850 C > T polymorphisms with generalized tonic clonic seizures among Indians.

C C Soundararajan1, A Adhin, M Tripathi, H K Prasad, S Jain, S Vivekanandhan.   

Abstract

Multiple avenues of research have provided evidence for the role of genetic and environmental factors in epilepsy. Previous studies indicated an association of debrisoquine hydroxylase (CYP2D6) with susceptibility to epilepsy. In this study, association of CYP2D6 100C > T and 2850C > T polymorphisms with generalized tonic clonic seizures (GTCS) among Indians has been analysed using case-control approach. A significant association of 2850C > T (P = 0.015) has been observed. Comparison between phenytoin toxic and others among patients showed no association of these polymorphisms with phenytoin toxicity.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16835697     DOI： 10.1007/s00702-006-0494-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  23 in total

Review 1.  Cytochrome P450 CYP2D6.

Authors:  C R Wolf; G Smith
Journal:  IARC Sci Publ       Date:  1999

2.  Epidemiology of epilepsy--Indian perspective.

Authors:  Biman Kanti Ray; Susanta Bhattacharya; Tejendra Nath Kundu; Shankar Prasad Saha; Shyamal Kumar Das
Journal:  J Indian Med Assoc       Date:  2002-05

Review 3.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

4.  pNAT and CYP2D6 gene polymorphism in epileptic patients.

Authors:  J T Borlak; V Harsany; H Schneble; K D Haegele
Journal:  Biochem Pharmacol       Date:  1994-11-01       Impact factor: 5.858

5.  Prevalence and pattern of epilepsy in India.

Authors:  R Sridharan; B N Murthy
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

6.  Epilepsies in twins: genetics of the major epilepsy syndromes.

Authors:  S F Berkovic; R A Howell; D A Hay; J L Hopper
Journal:  Ann Neurol       Date:  1998-04       Impact factor: 10.422

7.  Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations.

Authors:  G Alván; P Bechtel; L Iselius; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.

Authors:  H K Roh; M L Dahl; I Johansson; M Ingelman-Sundberg; Y N Cha; L Bertilsson
Journal:  Pharmacogenetics       Date:  1996-10

9.  Genetic polymorphism of CYP2D6 in North Indian subjects.

Authors:  V Lamba; J K Lamba; J B Dilawari; K K Kohli
Journal:  Eur J Clin Pharmacol       Date:  1998 Nov-Dec       Impact factor: 2.953

10.  A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease.

Authors:  Y Tsuneoka; Y Matsuo; K Iwahashi; H Takeuchi; Y Ichikawa
Journal:  J Biochem       Date:  1993-08       Impact factor: 3.387
View more
  3 in total

Review 1.  Cytochrome P450 2D6.

Authors:  Ryan P Owen; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2009-07       Impact factor: 2.089

2.  Pharmacogenetics and gender association with psychotic episodes on nortriptyline lower doses: patient cases.

Authors:  Irina Piatkov; Trudi Jones
Journal:  ISRN Pharm       Date:  2011-07-20

Review 3.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.